Annual report pursuant to Section 13 and 15(d)

Consolidated Balance Sheets

v3.10.0.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2018
Dec. 31, 2017
Assets    
Equity method investments $ 471,044 $ 522,615
Government receivables 497,464 519,485
Commercial receivables 447,196 473,452
Receivables held-for-sale 0 19,081
Real estate 365,370 340,824
Investments 169,793 151,209
Cash and cash equivalents 21,418 57,274
Other assets 182,628 166,232
Total Assets 2,154,913 2,250,172
Liabilities:    
Accounts payable, accrued expenses and other 36,509 25,645
Deferred funding obligations 72,100 153,308
Credit facilities 258,592 69,922
Non-recourse debt (secured by assets of $1,105 million and $1,545 million, respectively) 834,738 1,210,861
Convertible notes 148,451 147,655
Total Liabilities 1,350,390 1,607,391
Stockholders’ Equity:    
Preferred stock, par value $0.01 per share, 50,000,000 shares authorized, no shares issued and outstanding 0 0
Common stock, par value $0.01 per share, 450,000,000 shares authorized, 60,510,086 and 51,665,449 shares issued and outstanding, respectively 605 517
Additional paid in capital 965,384 770,983
Accumulated deficit (163,205) (131,251)
Accumulated other comprehensive income (loss) (1,684) (1,065)
Non-controlling interest 3,423 3,597
Total Stockholders’ Equity 804,523 642,781
Total Liabilities and Stockholders’ Equity $ 2,154,913 $ 2,250,172